141 related articles for article (PubMed ID: 19712735)
1. Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system.
Dosio F; Arpicco S; Stella B; Brusa P; Cattel L
Int J Pharm; 2009 Dec; 382(1-2):117-23. PubMed ID: 19712735
[TBL] [Abstract][Full Text] [Related]
2. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
Wang Y; Yu L; Han L; Sha X; Fang X
Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
[TBL] [Abstract][Full Text] [Related]
3. Composite micelles consisting of paclitaxel- and folic acid-carrying copolymers for treatment of Lewis lung cancer.
Zheng Y; Wan Y; Song X; Hu X; Liu S; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e123-4. PubMed ID: 22195794
[No Abstract] [Full Text] [Related]
4. Water-soluble taxol conjugates with dextran and targets tumor cells by folic acid immobilization.
Nakamura J; Nakajima N; Matsumura K; Hyon SH
Anticancer Res; 2010 Mar; 30(3):903-9. PubMed ID: 20393013
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
6. Photo-crosslinked biodegradable micelles for paclitaxel release.
Xiong J; Meng F; Zhong Z
J Control Release; 2011 Nov; 152 Suppl 1():e105-6. PubMed ID: 22195782
[No Abstract] [Full Text] [Related]
7. Reduction-responsive polymeric micelles for anticancer drug delivery.
Jiang X; Li L; Liu J; Zhuo R
J Control Release; 2011 Nov; 152 Suppl 1():e36-7. PubMed ID: 22195910
[No Abstract] [Full Text] [Related]
8. Synthesis, characterization and in vitro cytotoxicity studies of a macromolecular conjugate of paclitaxel bearing oxytocin as targeting moiety.
Cavallaro G; Maniscalco L; Campisi M; Schillaci D; Giammona G
Eur J Pharm Biopharm; 2007 May; 66(2):182-92. PubMed ID: 17182230
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel controlled delivery using a pH-responsive functional-AuNP/block-copolymer vesicular nanocarrier composite system.
Liaskoni A; Angelopoulou A; Voulgari E; Popescu MT; Tsitsilianis C; Avgoustakis K
Eur J Pharm Sci; 2018 May; 117():177-186. PubMed ID: 29477643
[TBL] [Abstract][Full Text] [Related]
11. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
13. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
14. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
Wu L; Tang C; Yin C
Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865
[TBL] [Abstract][Full Text] [Related]
15. Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
Wang Z; Hu X; Yue J; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e41-2. PubMed ID: 22195914
[No Abstract] [Full Text] [Related]
16. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate.
Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL
Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J; Niu R
Pharm Res; 2010 Sep; 27(9):1914-26. PubMed ID: 20582454
[TBL] [Abstract][Full Text] [Related]
18. Cys34-PEGylated Human Serum Albumin for Drug Binding and Delivery.
Mehtala JG; Kulczar C; Lavan M; Knipp G; Wei A
Bioconjug Chem; 2015 May; 26(5):941-9. PubMed ID: 25918947
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives.
Arpicco S; Stella B; Schiavon O; Milla P; Zonari D; Cattel L
Int J Pharm; 2013 Oct; 454(2):653-9. PubMed ID: 23701999
[TBL] [Abstract][Full Text] [Related]
20. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
Yoo HS; Park TG
J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
